MedPath

NAPROXEN CAPSULES 200 MG

NAPROXEN CAPSULES 200 MG

Dormant
DIN Number

02418835

Drug Class

Human

Market Date

Jun 19, 2015

Company
HC

Catalent Ontario Limited

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02418835
AIG Number0109634009
Classification & Schedule
C
Drug Class
Human
S
Schedule
OTC
A
ATC Code
M01AE02 NAPROXEN
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
AHFS Classification28:08.04.92
Health Canada Classification

ACTIVE INGREDIENTS (1)

NAPROXEN (NAPROXEN SODIUM, NAPROXEN)Active
Strength: 200 MG
Monograph: NAPROXEN (NAPROXEN SODIUM, NAPROXEN)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.